The effects of intrarenal infusions of calcium gluconate (10 and 100 ng Ca/kg/min) on renin secretion were studied in anesthetized mongrel dogs. In one group, the two doses of calcium were infused for 30 minutes each (1 ml/min). In a second group, the same doses were administered 30 minutes after the start of infusion of prostaglandin synthesis inhibitors (indomethacin 10 /ig/kg/min intrarenal or injection of meclofenamate 5 mg/kg i.v. bolus). Mean arterial pressure, renal blood flow, and glomerular nitration rate remained unchanged during the infusion of calcium in both groups. The infusion of 10 /*g Ca/kg/min increased renin secretion 77% and sodium excretion 123%. During the infusion of 100 /ug Ca/kg/min, renin secretion was not different from precalcium values, whereas urinary 6-keto-PGF, a , urine flow, sodium, potassium, and calcium excretion rates were increased (p<0.05). During the administration of prostaglandin synthesis inhibitors, the urinary 6-keto-PGF, a levels were reduced, and the infusion of 10 /ug Ca/kg/min failed to increase renin secretion, sodium excretion, or 6-keto-PGF, a excretion rates. The infusion of 100 /tg Ca/kg/min during prostaglandin synthesis inhibition did not modify urine flow or sodium excretion; however, potassium and calcium excretions increased. It is concluded that 1) the intrarenal infusion of small doses of calcium gluconate is capable of stimulating renin secretion through a prostaglandin-mediated mechanism, and 2) the stimulation of renin secretion as well as the increase in sodium excretion induced by calcium are independent of hemodynamk alterations. (Hypertension 1990;15(suppl I):I-149-I-152)
T he manner in which calcium influences renin secretion rate has been investigated using a variety of experimental conditions. 1 Although in vitro studies have yielded some inconclusive results, 1 there is a general consensus that the increase of calcium entry into the juxtaglomerular cells decreases renin secretion.
1 -2 It has been proposed that calcium plays a fundamental role in coupling the renin secretion responses to the myogenic vasoconstriction that is seen during renal blood flow (RBF) autoregulation. 3 The juxtaglomerular cells located in the afferent arterial wall are morphologically differentiated from the smooth muscle. 3 - 4 Consequently, the juxtaglomerular and smooth muscle cells can be subjected to similar changes in calcium kinetics induced by alterations in renal arterial pressure. 7 These findings suggest that the calcium-induced suppression of renin secretion might be modulated by the calcium-stimulated endothelial response of PGI 2 . The hypothesis tested by this study was that a small increase in the concentration of calcium into the renal artery will stimulate first the synthesis of PGI 2 in the endothelium, thus enhancing renin secretion. This effect, which was first suggested by Nadler et al, 8 should be prevented by prostaglandin synthesis inhibition. At higher concentrations, calcium can act directly on the juxtaglomerular cells, reducing renin secretion, as suggested by the study of Watkins et al. 9 Therefore, this study was undertaken to determine the effect on renin secretion of two doses of calcium gluconate infused into the renal artery of anesthetized dogs in the presence or in the absence of prostaglandin synthesis inhibition. The two doses of calcium gluconate (10 and 100 /ig/kg/min) were chosen from preliminary pilot studies in which a range of smaller doses than those reported by Watkins et al 9 and Kotchen and Guthrie 10 were tested. After completion of the surgical preparation, the dogs were allowed to equilibrate for 90 minutes before two 15-minute renal clearance periods. Saline was infused intrarenally during both the equilibration and precalcium infusion periods. After the basal clearances, intrarenal infusion of indomethacin (10 jig/kg/min) in a saline vehicle was begun and continued throughout the experiment in four dogs, whereas an intravenous bolus injection of meclofenamate (5 mg/kg) in a saline vehicle was administered to the other four dogs. Thirty minutes later, the eight dogs underwent an identical protocol in which two doses (10 and 100 /xg/kg/min) of calcium were sequentially given intrarenally for 30 minutes each. Calcium doses were isotonic solutions made from a calcium gluconate solution containing 0.465 meq Ca/ml. The remaining eight dogs received saline without prostaglandin synthesis inhibitors during the 30 minutes after the basal clearances, followed by the infusion of the two doses of calcium gluconate.
In all the dogs, urine samples were collected during the last 15 minutes of each 30-minute infusion. Blood samples from femoral artery and from renal vein were drawn at the middle of the 15-minute clearance period.
As previously mentioned, two different cyclooxygenase inhibitors were used to rule out any specific side effects inherent to the drug that are not related to prostaglandin inhibition. The results obtained with indomethacin and meclofenamate were pooled because no quantitative or qualitative differences were detected.
Renin activity in renal vein plasma and in artery plasma were determined by radioimmunoassay. Renin secretion was calculated as the product of the difference between venous and arterial plasma renin activities and renal plasma flow. Urinary 6-keto- prostaglandin Fi a (U6kPGF la ), the stable metabolite of PGI 2 , was measured by radioimmunoassay.
Sodium and potassium concentrations in plasma and in urine were measured with an electrolyte analyzer (Beckman E2A, Beckman Instrs., Inc., Brea, California). Calcium concentrations in plasma and in urine were measured by an atomic absorption spectrophotometer (model 357, Instrumentation Laboratory Inc., Lexington, Massachusetts). Plasma and urine inulin concentration was measured with the Anthrone method.
All values are expressed as mean±SEM. Data were analyzed with randomized block analysis of variance, Newman-Keuls multiple range test and Student's unpaired t test; p values less than 0.05 were considered significant.
Results
The intrarenal infusion of 10 ng Ca/kg/min induced a 77% increase of renin secretion from 112.1±26.1 to 198.7±56 ng angiotensin I (Ang I)/min (Figure 1 ). During the infusion of 100 fig Ca/kg/min, however, the values returned to precalcium levels (113.7±75.4 ng Ang I/min). The administration of prostaglandin inhibitors reduced the basal levels of renin secretion from 139.5±42 to 63.3±32.5 ng Ang I/min. After the administration of prostaglandin inhibitors, the infusion of 10 and 100 ^g Ca/kg/min failed to produce any Values represent mean±SEM of eight dogs during precalcium conditions (saline and indomethacin 10 /ig/kg/min or meclofenamate 5 mg/kg i.v., respectively) and calcium gluconate infusions (10 and 100 fj.g Ca/kg/min). Pre-Ca, precalcium; UV, urine flow; UNaV, sodium excretion rate; UKV, potassium excretion rate; UCaV, calcium excretion rate; GFR, glomerular filtration rate. t/><0.05, *p<0.01, and $p<0.001 as compared with respective precalcium levels.
significant alteration in renin secretion (24.1 ±11.2 and 61.4±2.8 ng Ang I/min, respectively) ( Figure 1 ). The precalcium control levels of MAP and RBF in both groups were 115±7 mm Hg and 113±11 ml/min without prostaglandin inhibitors and 118 ±6 mm Hg and 114±31 ml/min in the presence of indomethacin or meclofenamate. The intrarenal infusion of calcium did not induce significant alterations in MAP or RBF in the absence or in the presence of prostaglandin inhibitors. Glomerular filtration rate (GFR) also remained without significant variations in both groups (Table 1) .
In the control dogs that were not treated with prostaglandin inhibitors, the excretory rate of U6kPGF la during the precalcium control period was 906± 123 pg/min. The infusion of 10 fig Ca/kg/min did not modify U6kPGFi a levels (l,074±240 pg/min) but increased to 2,003±322 pg/min (p<0.05) during the infusion of 100 fig Ca/kg/min. The administration of prostaglandin inhibitors decreased U6kPGF la levels from 752±158 to 337±90 pg/min. These levels were not modified during the concomitant administration of 10 and 100 /xg Ca/kg/min (276±70 and 295±52 pg/ min, respectively) ( Figure 1) .
The administration of the two doses of calcium gluconate represents an approximate increase of 0.13 and 1.3 meq Ca/1, respectively, in calcium concentration of blood in the renal artery, based on an average renal plasma flow of 75 ml/min.
The infusion of both doses of calcium produced an increase (/?<0.05) in urinary sodium excretion rate (UNaV), whereas urine flow (UV), and urinary potassium excretion rate (UKV) increased during the infusion of 100 /xg Ca/kg/min (p<0.01). In the dogs treated with prostaglandin inhibitors, calcium infusions failed to alter UV and UNaV. UKV, however, increased (/?<0.01) with the infusion of 100 fig Ca/kg/min even in the presence of prostaglandin inhibitors (Table 1) .
Urinary calcium excretion (UCaV) was not significantly altered by the infusion of 10 fig Ca/kg/min but went up (p<0.0l) during the infusion of 100 fig Ca/kg/min. These alterations in UCaV were also observed in dogs treated with prostaglandin inhibitors (Table 1) .
Peripheral plasma concentration of sodium, potassium, and calcium were not altered by the infusion of either dose of calcium given in the presence or in the absence of prostaglandin inhibitors.
Discussion
The present study demonstrates that the intrarenal infusion of 10 fig Ca/kg/min increases renin secretion through a prostaglandin-mediated mechanism. This stimulation of renin secretion was not accompanied by any significant hemodynamic alterations but occurred in the presence of a significant increase in UNaV. Furthermore, the results also show that the increase in renin secretion induced by the infusion of 10 fig Ca/kg/min was reversed to control levels by the infusion of 100 fig Ca/kg/min. This latter effect was accompanied by a further increase in UNaV, whereas the hemodynamic parameters remained unchanged.
Three possible mechanisms could be involved in the regulation of renin secretion under our experimental conditions. 1) An increase of calcium influx into the juxtaglomerular cells would tend to decrease renin secretion. 1 2) Calcium might decrease renin secretion indirectly by increasing the delivery of sodium to the macula densa during natriuresis. 11 3) Calcium can stimulate the endothelial production of PGI 2 , which could enhance renin secretion. 7 The observed increase in renin secretion during the infusion of 10 fig Ca/kg/min suggests a prevalence of the stimulatory effect of PGI 2 over the two inhibitory mechanisms mentioned above.
During the infusion of 10 fig Ca/kg/min, there were no changes in the U6kPGF 1<T ; however, it has been reported that endothelial release of PGI 2 is likely to influence the smooth muscle in amounts that are not high enough to diffuse into circulation. 12 During the renal PGI 2 stimulation, the release of PGI 2 can be significantly increased and detected in the renal venous effluent 13 and in urine, 14 in amounts that are not proportional to the quantities that are being synthesized.
14 This assumption is supported by these results, in which the inhibition of prostaglandin synthesis prevents the stimulation of renin secretion. 1 The return of renin secretion to control levels during the infusion of 100 ng Ca/kg/min could indicate that the stimulatory effect of PGI 2 was countered by an inhibitory mechanism. A greater influx of calcium into the juxtaglomerular cells might initiate an inhibitory effect on renin secretion that offsets the stimulatory effects of PGI 2 . This could explain the normalization of renin secretion despite elevated levels of 6kPGF lo in urine.
The effect of the larger dose of calcium on renin secretion is in agreement with the results of Kotchen and Guthrie. 10 These authors found that the intrarenal infusion of 300 /ng/kg/min of calcium chloride or calcium gluconate reduced renin secretion. They postulated that calcium could stimulate sodium delivery to distal tubules, inducing a decrease in renin secretion through the macula densa. In our experiment, this mechanism might have been important during the administration of 100 fig Ca/kg/min because renin secretion was reversed to control values in the presence of increased UNaV. The relative importance of the macula densa mechanism in the inhibition of renin secretion was suggested by Watkins et al, 9 in that the infusion of 250 ng Ca/kg/min in sodiumdepleted dogs inhibited renin secretion without altering UNaV. Furthermore, they found that the intrarenal infusion of calcium can reduce renin secretion in nonfiltering kidneys in which the tubular function has been abolished. 9 They concluded that the inhibitory effect of calcium on renin secretion was produced through a direct action on juxtaglomerular cells.
An important experimental condition for detecting the stimulatory effect of calcium on renin secretion can be the basal levels before its administration. In the experiments by Watkins and Kotchen and their colleagues, 9 -10 in which calcium induced a decrease in renin secretion, the dogs had high base line renin levels. In contrast, our results and those of Iwao 15 were obtained in dogs with low basal levels of renin secretion.
These results suggest that 1) the intrarenal infusion of small doses of calcium gluconate are capable of stimulating renin secretion through a prostaglandinmediated mechanism, and 2) the stimulation of renin secretion as well as the increase in UNaV induced by calcium are independent of hemodynamic alterations.
